Results 111 to 120 of about 20,748 (167)

Concurrent Presentation of Pure Red Cell Aplasia and Myeloproliferative Neoplasm, Unclassifiable With JAK2 and MPL Mutations. [PDF]

Case Rep Hematol
Li Q, Tan L, Wang X, Fan Q.
europepmc   +1 more source

Prognostic utility of macrophage polarization (CD68/CD163 ratio) in Egyptian JAK2 positive myeloproliferative neoplasm patients: a single center study. [PDF]

Diagn Pathol
Mahgoub SMA, Yehia MSM, Arafat AMA.
europepmc   +1 more source

Predictors of Symptom Scores in Myeloproliferative Neoplasms: A Real-World Retrospective Cohort Study. [PDF]

Cancer Med
Khan MA, Naqvi SAA, Camoriano JK, Arana Yi CY, Andres JT, Blocher JL, Kosiorek HE, Riaz IB, Palmer JM.   +8 more
europepmc   +1 more source

The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies. [PDF]

Blood Lymphat Cancer
Reynolds SB, Komrokji R, Kuykendall AT.
europepmc   +1 more source

Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison. [PDF]

Ann Hematol
Palandri F, Kapetanakis V, Dobi B, Breccia M, Palumbo GA, Abruzzese E, Bonifacio M, Tiribelli M, Elli EM, Morsia E, Branzanti F, Ellis CE, Ballew N, Liu T, Phiri K, Sen Nikitas F, Zhang S, Patnaik D.   +17 more
europepmc   +1 more source

Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis. [PDF]

Biomark Res
Coltro G, Videschi V, Gesullo F, Violi F, Balliu M, Vannucchi AM, Guglielmelli P.   +6 more
europepmc   +1 more source

[Myelofibrosis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1975
openaire   +1 more source

Nutritional factors and survival in a cohort of patients with myelofibrosis. [PDF]

Front Nutr
Buscemi S, Colombrita P, Santoro M, Randazzo C, Buscemi C, Barile AM, Caruso R, Lombardo M, Mancuso S, Gambino O, Bazan G, Siragusa S.   +11 more
europepmc   +1 more source

Masking as Myelofibrosis: A Case of Tp53 Mutated Acute Erythroid Leukemia Presenting With Pancytopenia and Bone Pain. [PDF]

Case Rep Hematol
Parker K, Cutrer RC.
europepmc   +1 more source